In SAT, the pan-macrophage marker CD68 and the M2-type macrophage markers MSR1/CD204 and MRC1/CD206 were found upregulated in patients with NAFLD (Table 3, Supplementary Figure S2). Here, MRC1 is linked to metabolic dysfunction-associated steatotic liver disease.